Stephane van Rooijen

Stephane van Rooijen

Vorstandsvorsitzender bei Dynacure SA

55 Jahre
Consumer Services
Health Technology
Health Services

Ursprung des Netzwerks ersten Grades von Stephane van Rooijen

EinheitArt der EinheitIndustrie
14
Subsidiary Medical/Nursing Services 14
10
Holding Company Miscellaneous Commercial Services 10
3
Subsidiary Pharmaceuticals: Major 3
2
Holding Company Pharmaceuticals: Major 2

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Stephane van Rooijen

UnternehmenSektorVerknüpfte PersonenHauptposition
IONIS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Brett Monia

Chris Mirabelli

Founder

Founder

Medical Specialties

Georges Gemayel

Frédéric Chéreau

Jean Franchi

Corporate Officer/Principal

Corporate Officer/Principal

Comptroller/Controller/Auditor

Pharmaceuticals: Major

Georges Gemayel

Chris Mirabelli

Chairman

Director/Board Member

MDXHEALTH SA Medical Specialties

Raphaël Wisniewski

Director/Board Member

SHIRE Pharmaceuticals: Major

Helen Lillistone

Chris Freitag

Corporate Officer/Principal

Corporate Officer/Principal

POXEL Pharmaceuticals: Major

Raphaël Wisniewski

Director/Board Member

Pharmaceuticals: Generic

Raphaël Wisniewski

Director/Board Member

Industrial Machinery

Raphaël Wisniewski

Director/Board Member

Investment Banks/Brokers

Raphaël Wisniewski

Corporate Officer/Principal

VALERIO THERAPEUTICS Pharmaceuticals: Major

Rémi Droller

Director/Board Member

VOYAGEURS DU MONDE Other Consumer Services

Raphaël Wisniewski

Director/Board Member

Investment Managers

Rémi Droller

Private Equity Investor

Biotechnology

Raphaël Wisniewski

Director/Board Member

Pharmaceuticals: Major

Raphaël Wisniewski

Director/Board Member

Biotechnology

Rémi Droller

Director/Board Member

THERADIAG Medical Specialties

Rémi Droller

Director/Board Member

SUPERSONIC IMAGINE Medical Specialties

Raphaël Wisniewski

Director/Board Member

École des Hautes Études Commerciales de Paris College/University

Raphaël Wisniewski

Graduate Degree

IMPLANET SA Medical Specialties

Raphaël Wisniewski

Director/Board Member

Pharmaceuticals: Generic

Georges Gemayel

Rémi Droller

Chairman

Director/Board Member

ADOCIA Pharmaceuticals: Major

Rémi Droller

Director/Board Member

Biotechnology

Rémi Droller

Raphaël Wisniewski

Director/Board Member

Director/Board Member

Investment Managers

Rémi Droller

Private Equity Investor

Electronic Equipment/Instruments

Raphaël Wisniewski

Director/Board Member

ORPHAZYME A/S Pharmaceuticals: Major

Georges Gemayel

Rémi Droller

Chairman

Director/Board Member

Financial Conglomerates

Rémi Droller

Corporate Officer/Principal

Miscellaneous Commercial Services

Rémi Droller

Director/Board Member

DIMENSION THERAPEUTICS INC Biotechnology

Georges Gemayel

Jean Franchi

Director/Board Member

Director of Finance/CFO

Axonics Europe SAS

Raphaël Wisniewski

Chief Executive Officer

Pharmaceuticals: Major

Rémi Droller

Raphaël Wisniewski

Director/Board Member

Director/Board Member

Financial Conglomerates

Kentaro Shirahata

Marc Stuart Page

Director/Board Member

Director/Board Member

DISC MEDICINE, INC. Biotechnology

Georges Gemayel

Jean Franchi

Director/Board Member

Director of Finance/CFO

CELLNOVO Medical Specialties

Raphaël Wisniewski

Director/Board Member

Miscellaneous Commercial Services

Raphaël Wisniewski

Director/Board Member

Winch Italy Holdings 1 SARL

Raphaël Wisniewski

Corporate Officer/Principal

EPG Investment Partners SA

Raphaël Wisniewski

Chairman

Winch Italy Holding 2 SARL

Raphaël Wisniewski

Director/Board Member

Statistik

International

Frankreich 24
Vereinigte Staaten 13
Schweiz 4
Niederlande 4
Luxemburg 4

Sektoral

Health Technology 33
Finance 7
Consumer Services 4
Commercial Services 3
Producer Manufacturing 2

Operativ

Director/Board Member 155
Corporate Officer/Principal 49
Chairman 32
Independent Dir/Board Member 21
Chief Executive Officer 15
  1. Börse
  2. Insiders
  3. Stephane van Rooijen
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT